Rationale and methodology for a European pooled analysis of postmarketing interventional and observational studies of insulin glargine 300 U/mL in diabetes : protocol of REALI project
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: 10.1136/bmjopen-2019-033659
- Event
-
Veröffentlichung
- (where)
-
Aachen
- (who)
-
Universitätsbibliothek der RWTH Aachen
- (when)
-
2020
- Creator
-
Freemantle, Nick
Bonadonna, Riccardo C.
Gourdy, Pierre
Mauricio, Didac
Müller-Wieland, Dirk
Bigot, Gregory
Ciocca, Alice
Mauquoi, Celine
Rollot, Mélissa
Bonnemaire, Mireille
- DOI
-
10.18154/RWTH-CONV-244577
- URN
-
urn:nbn:de:101:1-2023110100333178252023
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Freemantle, Nick
- Bonadonna, Riccardo C.
- Gourdy, Pierre
- Mauricio, Didac
- Müller-Wieland, Dirk
- Bigot, Gregory
- Ciocca, Alice
- Mauquoi, Celine
- Rollot, Mélissa
- Bonnemaire, Mireille
- Universitätsbibliothek der RWTH Aachen
Time of origin
- 2020
Other Objects (12)
Impact of Age on the Effectiveness and Safety of Insulin Glargine 300 U/mL: Results from the REALI European Pooled Data Analysis
Impact of age on the effectiveness and safety of insulin glargine 300 U/mL: results from the REALI European Pooled Data Analysis
Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
Safety of nivolumab monotherapy in five cancer types: pooled analysis of post-marketing surveillance in Japan
Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis
Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis
Glycaemic control with insulin glargine 300 u/ml in individuals with type 2 diabetes and chronic kidney disease: a REALI european pooled data analysis
Effectiveness and Safety of iGlarLixi (Insulin Glargine 100 U/mL Plus Lixisenatide) in Type 2 Diabetes According to the Timing of Daily Administration: Data from the REALI Pooled Analysis
Effectiveness and safety of iGlarLixi (Insulin Glargine 100 U/mL plus Lixisenatide) in type 2 diabetes according to the timing of daily administration: data from the REALI pooled analysis
Glycaemic Control with Insulin Glargine 300 U/mL in Individuals with Type 2 Diabetes and Chronic Kidney Disease: A REALI European Pooled Data Analysis
Clinical Use of Insulin Glargine 300 U/mL in Adults with Type 2 Diabetes: Hypothetical Case Studies
Use of Insulin Glargine 100 U/mL for the Treatment of Type 2 Diabetes Mellitus in East Asians: A Review
Impact of Age on the Effectiveness and Safety of Insulin Glargine 300 U/mL: Results from the REALI European Pooled Data Analysis
Impact of age on the effectiveness and safety of insulin glargine 300 U/mL: results from the REALI European Pooled Data Analysis
Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
Safety of nivolumab monotherapy in five cancer types: pooled analysis of post-marketing surveillance in Japan
Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis
Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis
Glycaemic control with insulin glargine 300 u/ml in individuals with type 2 diabetes and chronic kidney disease: a REALI european pooled data analysis
Effectiveness and Safety of iGlarLixi (Insulin Glargine 100 U/mL Plus Lixisenatide) in Type 2 Diabetes According to the Timing of Daily Administration: Data from the REALI Pooled Analysis
Effectiveness and safety of iGlarLixi (Insulin Glargine 100 U/mL plus Lixisenatide) in type 2 diabetes according to the timing of daily administration: data from the REALI pooled analysis
Glycaemic Control with Insulin Glargine 300 U/mL in Individuals with Type 2 Diabetes and Chronic Kidney Disease: A REALI European Pooled Data Analysis
Clinical Use of Insulin Glargine 300 U/mL in Adults with Type 2 Diabetes: Hypothetical Case Studies
Use of Insulin Glargine 100 U/mL for the Treatment of Type 2 Diabetes Mellitus in East Asians: A Review
Impact of Age on the Effectiveness and Safety of Insulin Glargine 300 U/mL: Results from the REALI European Pooled Data Analysis
Impact of age on the effectiveness and safety of insulin glargine 300 U/mL: results from the REALI European Pooled Data Analysis
Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
Safety of nivolumab monotherapy in five cancer types: pooled analysis of post-marketing surveillance in Japan
Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis
Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis
Glycaemic control with insulin glargine 300 u/ml in individuals with type 2 diabetes and chronic kidney disease: a REALI european pooled data analysis
Effectiveness and Safety of iGlarLixi (Insulin Glargine 100 U/mL Plus Lixisenatide) in Type 2 Diabetes According to the Timing of Daily Administration: Data from the REALI Pooled Analysis
Effectiveness and safety of iGlarLixi (Insulin Glargine 100 U/mL plus Lixisenatide) in type 2 diabetes according to the timing of daily administration: data from the REALI pooled analysis
Glycaemic Control with Insulin Glargine 300 U/mL in Individuals with Type 2 Diabetes and Chronic Kidney Disease: A REALI European Pooled Data Analysis
Clinical Use of Insulin Glargine 300 U/mL in Adults with Type 2 Diabetes: Hypothetical Case Studies